Reference
Tepper SJ, MD DHC, Ashina M, Brandes JL, Friedman DI, Reuter U, Cheng S, Nilsen J, Leonardi DK, Lenz RA, Mikol DD (2019) Erenumab in chronic migraine with medication overuse. Subgroup analysis of a randomized trial. Neurology 92:e2309–e2320
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
I certify that there is no actual or potential conflict of interest in relation to this article.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Disco, C., Billo, G., De Boni, A. et al. Efficacy of erenumab 70 mg in chronic migraine: Vicenza experience. Neurol Sci 41 (Suppl 2), 479–480 (2020). https://doi.org/10.1007/s10072-020-04665-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04665-2